Long-term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab

Main Article Content

Mark Lebwohl
Andrew Blauvelt
Alan Menter
Kim Papp
Abby Jacobson

Keywords

psoriasis, brodalumab

Abstract

Abstract not available.

References

1. Papp et al. N Engl J Med. 2012;366:1181-1189.

2. Papp et al. J Am Acad Dermatol. 2014;71:1183-1190.